| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Brazil | 4 | |
| #2 | Canada | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Australia | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | Republic of Korea | 2 | |
| #7 | Mexico | 2 | |
| #8 | Singapore | 2 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wang Chang Yi | 17 |
| #2 | Chang Yi Wang | 7 |
| #3 | Lin Feng | 1 |
| #4 | Ding Shuang | 1 |
| #5 | Wang Chang | 1 |
| #6 | Chen Jiun | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020140106A1 | Peptide immunogens targeting interleukin 6 (il-6) and formulations thereof for immunotherapy of diseases impacted by il-6 dysregulation | |
| WO2020132275A1 | Artificial promiscuous t helper cell epitopes as immune stimulators for synthetic peptide immunogens | |
| CA3099296A1 | Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response | |
| MX2019001814A | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients. | |
| CA2961464A1 | Treatment and functional cure of hiv infection by monoclonal antibodies to cd4 mediating competitive hiv entry inhibition |